FDA Approves First Transdermal Patch for Depression

Drug Industry Daily
KEYWORDS FDA / Rx
A A

The FDA has approved Somerset Pharmaceuticals’ experimental depression treatment Emsam, the first transdermal patch for the treatment of major depressive disorder (MDD) in adults.

To View This Article:

Login

Subscribe To Drug Industry Daily